| Document |
Document Title |
|
JP2007314890A |
To provide an effective method for efficiently recovering copper from a copper-containing substance (particularly copper from a copper sulfide such as chalcopyrite and chalcocite), which realizes a high copper recovery rate at a reduced ...
|
|
JP3987449B2 |
An organic EL device, having an anode and a cathode, and at least one organic luminescent medium including a compound of the formula: wherein: R1, and R2 are individually alkyl of from 1 to 20 carbon atoms, aryl, substituted aryl, carboc...
|
|
JP3972571B2 |
To provide an optical recording medium which can deal with high- speed recording and excels in recording sensitivity by using a novel metal chelate pigment in a recording layer. The metal chelate pigment is a chelate pigment of an azo co...
|
|
JP2007522116A |
The invention relates to conformationally constrained mimetics of Smac which function as inhibitors of Inhibitor of Apoptosis Proteins. The invention also relates to the use of these mimetics for inducing apoptotic cell death and for sen...
|
|
JP2007522193A |
The invention provides novel isomers of dihydrotetrabenazine, individual enantiomers and mixtures thereof wherein the dihydrotetrabenazine is a 3,11 b-cis-dihydrotetrabenazine. Also provided are methods for the preparation of the novel i...
|
|
JP3919251B2 |
To easily produce a new dicyanopyrazine derivative, expressed by a specific formula and useful as a synthetic raw material for an optical recording material, a photoelectric conversion material, etc., or as a fluorochrome. This dicyanopy...
|
|
JP2007512364A |
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A...
|
|
JP2007112738A |
To provide a new agent capable of effectively recovering an once declined digestive organ motility function by using an easily available material.The digestive organ motility activating agent comprises as an effective component, at least...
|
|
JP3901945B2 |
The present invention provides non-steroidal compounds of formula I which are selective modulators (i.e., agonist and antagonists) of a steroid receptor, specifically, the glucocorticoid receptor. The present invention also provides phar...
|
|
JP2007505842A |
The present invention relates to specific photochromic phenanthropyrans as well as to their use in synthetic resin materials of all types, especially for ophthalmic purposes. In particular, the present invention relates to photochromic c...
|
|
JP2007056271A |
To provide a cationic azo compound with julolidine units that can be used as a direct dye for keratin fibers, in particular, human keratin fiber such as the hair.The present application relates the use of cationic azo compound with julol...
|
|
JP2007502786A |
Novel compounds of formula (I) are disclosed, where R1, R1', L, Y, m and p have the meanings given in claim 1 , which are inhibitors of tyrosine kinases, in particular, TIE-2 and Raf kinases and can be used for the treatment of tumors.
|
|
JP3850450B2 |
A compound represented by the formula (I): wherein, for example, R<1> is optionally substituted aralkyl, Z is nitrogen atom which optionally substituted with alkyl, X<1> is -CH2NHCO-, X<2> is phenylene, X<3> is a bond, Y<2> is optionally...
|
|
JP3833738B2 |
To obtain the new compound useful as an antibacterial agent and especially exhibiting a storing antibacterial activity against gram-positive bacteria, particularly quinolone-resistant bacteria including MRSA. This compound of formula I (...
|
|
JP3826182B2 |
PURPOSE: To obtain the subject new compound having agonist action on RXR and useful as an immunosuppressive agent in organ transplantation, a preventing and treating agent, etc., of autoimmune diseases (e.g. psoriasis or chronic rheumati...
|
|
JP2006520385A |
This invention relates to fused pyrrole compounds of Formula (I): and pharmaceutically acceptable salts and prodrugs thereof, wherein V1, V2, V3, V4, R1, R2, R3, W1 and W2 are as defined herein. The compounds of this invention may be use...
|
|
JP2006518757A |
The present invention is directed to compounds of formulae (I and II)(wherein A, D, E, X, l, m, n and R1 through R18 are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are us...
|
|
JP2002521334A5 |
|
|
JP3793714B2 |
To obtain an antiallergic agent and an antiinflammatory agent having excellent antiallergic actions and antiinflammatory actions with slight adverse effects. The antiallergic agent and the antiinflammatory agent comprise d-corydaline and...
|
|
JP3782809B2 |
To provide a charge transfer substance having an amino-substituted hydrozone group and an epoxy group, an organic photoreceptor and an electrophotographic image forming apparatus containing the substance, and a method for forming an elec...
|
|
JP2006131519A |
To provide an organic electroluminescent element having high light emission efficiency and heat resistance with extremely long life and obtain a condensed ring containing compound for realizing the same.The organic electroluminescent ele...
|
|
JP2006507287A |
Novel and nonobvious compounds that function, alone or in combination, as nuclear hormone receptors for the stimulation and/or improvement of murine, mammalian skin. Specifically, beta-ionol analog and fatty acid analog compounds that ar...
|
|
JP2006056885A |
To provide a dye useful in various aqueous base applications, especially in dyeing cells, and in assay including the analyses of nucleic acids such as a bonding of proteins and/or hybridization assay and nucleic acid sequence determinati...
|
|
JP2006503106A |
This invention relates to compounds of the formula 1 wherein X, Y, Z, A, R<1>, R<2>, R<3>, R<4>, R<9>, W<1 >and W<2 >are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of centr...
|
|
JP2005536532A |
Compounds of the following formula: are effective antimicrobial agents.
|
|
JP2005530691A |
The invention provides novel tyloindicines analogues and related processes, pharmaceutical compositions, and methods. The novel tyloindicines are useful in a wide variety of antiviral, antineoplastic, antibacterial, and anti-inflammatory...
|
|
JP2005527629A |
The invention relates to the new arginine salt forms of RS-(.plusmn.)-9-fluo ro- 6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H
- benzo~i,j~quinolizine-2-carboxylic acid, S-(-)-9-fluoro-6,7-dihydro-8-(4- hydroxypiperidin-1-...
|
|
JP2005522468A |
A compound of formula I, wherein X, Z, R1 to R10, R15, R16, m, n, r and t are as defined in claim 1, or a pharmaceutically acceptable salt or ester thereof, useful as an alpha-2 antagonist. The compounds of formula I can be used for the ...
|
|
JP2005196206A |
To provide a charge transport material which enables an organophotoreceptor to form a high-quality image and to hold the high-quality image, even after iterative use.The charge transport compound is expressed by a chemical Formula (1). I...
|
|
JPWO2003070277A1 |
The present invention relates to the use of a compound having an agonistic activity to the cannabinoid receptor, a prodrug, a pharmaceutically acceptable salt or solvate thereof for the preparation of an antipruritic, wherein the compoun...
|
|
JP2005504649A |
An optical recording medium having at least a recording layer 11 and a light transmitting layer 13 formed on a substrate 10 , in which the recording layer 11 is made of an organic material for absorbing an incident light of wavelength of...
|
|
JP2005500666A |
The application relates to an organic electroluminescent device which contains 2,5 diaminoterephthalic acid derivatives of formula 1a as emitter substances in one or several emitter layers in a pure or doped manner. The ring A is a tripl...
|
|
JP2004359681A |
To provide a new charge transport compound, to provide an organic photoreceptor containing the same, and to provide an electrophotographic image formation method using the same.The charge transport compound has a plurality of hydrazone-b...
|
|
JP2004537606A |
The present invention provides compositions and methods for controlling an helminth or arthropod pest. In a preferred embodiment of the invention provided herein, the compositions comprise compounds which alter the 5-HT3 receptor of the ...
|
|
JP2004334210A |
To provide an organophotoreceptor having electrostatic characteristics of producing high-quality images by maximizing the charge acceptance voltage Vacc and minimizing the discharge voltage Vdis on discharging, to provide a charge transp...
|
|
JP2004534344A |
Optical data medium containing a preferably transparent substrate which is optionally already coated with one or more barrier layers and on the surface of which an information layer which can be recorded on using light, optionally one or...
|
|
JP2004525800A |
Optical data carrier comprising a preferably transparent substrate which may, if desired, have previously been coated with one or more reflection layers and to whose surface a light-writeable information layer, if desired one or more ref...
|
|
JP2004525799A |
Optical data carrier comprising a preferably transparent substrate which may, if desired, have previously been coated with one or more reflection layers and to whose surface a light-writeable information layer, if desired one or more ref...
|
|
JP2004525801A |
Optical data carrier comprising a preferably transparent substrate which may, if desired, have previously been coated with a protective layer and to whose surface a light-writable information layer, if desired a protective layer, if desi...
|
|
JP2004525798A |
Optical data carrier comprising a preferably transparent substrate which may, if desired, have previously been coated with one or more reflection layers and to whose surface a light-writeable information layer, if desired one or more ref...
|
|
JP2004524199A |
An optical data storage medium containing a preferably transparent substrate which has optionally already been coated with one or more reflecting layers and onto the surface of which a photorecordable information layer, optionally one or...
|
|
JP2004524198A |
Optical data carrier comprising a preferably transparent substrate which may, if desired, have previously been coated with a reflection layer and to whose surface a light-writeable information layer, if desired a reflection layer and if ...
|
|
JP2004524194A |
Optical data carrier comprising a preferably transparent substrate which may, if desired, have previously been coated with one or more reflection layers and to whose surface a light-writeable information layer, if desired one or more ref...
|
|
JP2004524201A |
An optical data storage medium containing a preferably transparent substrate which has optionally already been coated with one or more reflecting layers and onto the surface of which a photorecordable information layer, optionally one or...
|
|
JP2004524195A |
An optical data storage medium containing a preferably transparent substrate which has optionally already been coated with one or more reflecting layers and onto the surface of which a photorecordable information layer, optionally one or...
|
|
JP2004523396A |
An optical data storage medium containing a preferably transparent substrate which has optionally already been coated with one or more reflecting layers and onto the surface of which a photorecordable information layer, optionally one or...
|
|
JP2004523395A |
Optical data carrier comprising a preferably transparent substrate which may, if desired, have previously been coated with one or more reflection layers and to whose surface a light-writeable information layer, if desired one or more ref...
|
|
JP2004515549A |
Compounds having the general structure:are effective antimicrobial agents.
|
|
JP2004515548A |
Compounds of the following formula:are effective antimicrobial agents.
|
|
JP2004510712A |
The invention features substituted fused bicyclic compounds, pharmaceutical compositions containing them, and methods of using them to treat or prevent histamine-mediated diseases and conditions.
|
